US · biotech · drug discovery · pharmaceutical
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Apr 2026 · $100M
Deerfield Management lead, Alexandria Venture Investments, Longwood Fund, Regeneron Ventures, Binney Street Capital of Dana-Farber Cancer Institute
Reported by TechStartups
Missing a round, or an investor who was in one? Tell us.